Clinical trials
Completed Neoplasm Metastasis trials in Hong Kong
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 4 |
| Novartis Pharmaceuticals | 3 |
| Amgen | 2 |
| Bayer | 2 |
| GlaxoSmithKline | 2 |
| NantCell, Inc. | 2 |
| Puma Biotechnology, Inc. | 2 |
| The University of Hong Kong | 2 |
| Chinese University of Hong Kong | 1 |
| Janssen Research & Development, LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 24 |
| Breast Neoplasms | 7 |
| Neoplasms | 6 |
| Colorectal Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Colonic Neoplasms | 2 |
| Rectal Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Anemia | 1 |
| Blood Protein Disorders | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.